![Frontiers | Integrated Genomic Profiling and Drug Screening of Patient-Derived Cultures Identifies Individualized Copy Number-Dependent Susceptibilities Involving PI3K Pathway and 17q Genes in Neuroblastoma Frontiers | Integrated Genomic Profiling and Drug Screening of Patient-Derived Cultures Identifies Individualized Copy Number-Dependent Susceptibilities Involving PI3K Pathway and 17q Genes in Neuroblastoma](https://www.frontiersin.org/files/Articles/709525/fonc-11-709525-HTML/image_m/fonc-11-709525-g001.jpg)
Frontiers | Integrated Genomic Profiling and Drug Screening of Patient-Derived Cultures Identifies Individualized Copy Number-Dependent Susceptibilities Involving PI3K Pathway and 17q Genes in Neuroblastoma
![Analysis of Neuroblastoma Mortality Rates before and after the Cessation of the Mass Screening Program According to Vital Statistics of Japan Data Analysis of Neuroblastoma Mortality Rates before and after the Cessation of the Mass Screening Program According to Vital Statistics of Japan Data](https://www.omicsonline.org/articles-images/epidemiology-mass-screening-7-305-g005.png)
Analysis of Neuroblastoma Mortality Rates before and after the Cessation of the Mass Screening Program According to Vital Statistics of Japan Data
![Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study - The Lancet Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study - The Lancet](https://www.thelancet.com/cms/attachment/2000995621/2003688051/gr1.jpg)
Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study - The Lancet
![Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma | Science Translational Medicine Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma | Science Translational Medicine](https://www.science.org/cms/asset/2e5554a9-4a75-414b-905a-dfb63ec18155/aba4434-f1.gif)
Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma | Science Translational Medicine
The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan:
![Identification of Novel Small-Molecule Kinase Modulators for the Treatment of Neuroblastoma | SpringerLink Identification of Novel Small-Molecule Kinase Modulators for the Treatment of Neuroblastoma | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40487-020-00113-5/MediaObjects/40487_2020_113_Fig1_HTML.png)